Assessing Merck and Moderna’s mRNA cancer vaccine
AI Summary
The article discusses data on a cancer vaccine being developed by Merck and Moderna, presented at the annual meeting of the European Society for Medical Oncology. The results are reviewed on the STAT News podcast “The Readout LOUD.”
On this week's “The Readout LOUD,” we discuss the latest cancer data presented at the annual meeting of the European Society for Medical Oncology.